- Service Name
BiomX Phage Therapy
- Industry
Biotechnology, therapeutics, microbiome therapeutics, phage therapy
- Main Value Proposition
BiomX offers advanced phage therapies that specifically target and destroy harmful bacteria, providing a novel solution for chronic disease management.
- Description
BiomX is a microbiome therapeutics company that develops both natural and engineered phage therapies aimed at eradicating harmful bacteria associated with chronic diseases. Their innovative approach includes personalized treatments tailored to target specific bacterial threats.
- Key Features
Customized phage cocktails; Targeted treatments for chronic diseases; Proprietary bacterial target discovery; Collaboration with leading pharmaceutical companies
- Use Cases
Treatment of cystic fibrosis; Management of diabetic foot osteomyelitis; Development of biomarkers for inflammatory bowel disease
- Competitive advantages
Unique microbiome-based biomarker discovery platform (XMarker); Strong collaborations with major pharmaceutical companies; Focus on chronic diseases with significant unmet medical needs
- Strengths
BiomX's strengths lie in its innovative technology, strong scientific backing, and strategic partnerships that enhance its research and development capabilities.
- Positioning
BiomX positions itself as a leader in the emerging field of phage therapy, focusing on personalized medicine to address chronic bacterial infections.
- Audience
The primary target users include healthcare professionals, researchers in microbiome therapeutics, and patients suffering from chronic bacterial infections.
- CTA
Learn More
- Tags
phage therapy
microbiome
chronic diseases
biotechnology
- Tagline
Advancing Medicine. Precisely.
- Tone of Voice
Innovative, authoritative, scientific
- Differentiation
BiomX stands out in the market by combining natural and engineered phage therapies with a personalized approach, leveraging proprietary technology developed by world-renowned scientists.
- Brand Positioning
BiomX is identified as an innovative and cutting-edge company in the biotechnology sector, dedicated to advancing medical treatments through phage therapy.
- Founded
2015-01-01
- Founders
Eran Elinav
Rotem Sorek
Timothy K. Lu